Elevance Health Inc (ELV)

Industry Healthcare Plans


This stock can be held in an Investment ISA and an Investment Account
Sell

$384.01

Buy

$400.50

arrow-up$1.77 (+0.45%)

Prices updated at 04 Mar 2025, 13:31 EST
| Prices minimum 15 mins delay
|
Prices in USD

Anthem Inc is a health benefits company offering a network-based managed care plans to the large and small employer, individual, Medicaid and Medicare markets. Its business segments are Commercial and Specialty Business, Government Business and Other.

Income statement

20232024
171,340m176,810m
--
--
--
5,987m5,980m
--
Sales, General and administrative--
Interest expenses1,030m1,185m
Provision for income taxes1,724m1,933m
Operating expenses--
Income before taxes7,715m7,904m
Net income available to common shareholders5,987m5,980m
25.3825.81
Net interest income-1,030m-1,185m
Advertising and promotion--
Net investment income, net420m472m
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)25.2225.68
Free cash flow per share34.52743.7206
Book value/share164.8553192.4348
Debt equity ratio0.5914110.707201

Balance sheet

20232024
Current assets--
Current liabilities--
Total capital62,552m70,533m
Total debt25,120m31,232m
Total equity39,306m41,315m
Total non current liabilities--
Loans23,246m29,218m
Total assets108,928m116,889m
Total liabilities--
Cash and cash equivalents6,526m8,288m
Common stock233m227m

Cash flow

20232024
Cash at beginning of period7,387m6,526m
Cash dividends paid-1,395m-1,508m
6,765m4,552m
Investments (gains) losses-5,572m-5,167m
6,526m8,288m
Net income--
8,061m5,808m
-1,296m-1,256m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.